AMSTERDAM (Reuters) – The European medicines watchdog on Tuesday said it was aware of a decision by its U.S. counterpart to pause the administration of Johnson & Johnson’s COVID-19 vaccine due to rare instances of blood clots.
In a statement the European Medicines Agency (EMA) said it is not clear there is a link between the vaccine and the incidents and its safety committee is continuing a review announced last week.
(Reporting by Toby Sterling, Editing by Franklin Paul)
Man City beats Brighton 4-0 to stay on course for another Premier League title. Phil Foden scores 2
The NFL draft gives players a chance to flaunt their style on the red carpet
QB Jaden Rashada transfers to Georgia after leaving Arizona State
Suns’ Big 3 in a big pickle, down 2-0 against the Timberwolves as series moves to Phoenix
Charlie Woods, son of Tiger, shoots 81 in local qualifier and fails in bid to play in US Open
Fed plan to rebuild Pacific sardine population was insufficient, California judge finds
Net neutrality restored as FCC votes to regulate internet providers
Burkina Faso’s army massacred over 200 civilians in a village raid, Human Rights Watch says
Tennessee lawmakers OK bill criminalizing adults who help minors receive gender-affirming care
Hamas again raises the possibility of a 2-state compromise. Israel and its allies aren’t convinced
Minneapolis smokers to pay some of the highest cigarette prices in US with a $15 per-pack minimum
UN report says 282 million people faced acute hunger in 2023, with the worst famine in Gaza
Malaria is still killing people in Kenya, but a vaccine and local drug production may help
US births fell last year, marking an end to the late pandemic rebound, experts say
